These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 20061858)
1. Potential subtherapeutic linezolid and meropenem antibiotic concentrations in a patient with severe burns and sepsis. Hallam MJ; Allen JM; James SE; Donaldson PM; Davies JG; Hanlon GW; Dheansa BS J Burn Care Res; 2010; 31(1):207-9. PubMed ID: 20061858 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries. Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078 [TBL] [Abstract][Full Text] [Related]
4. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries]. Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections. MacGowan AP J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii17-25. PubMed ID: 12730139 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient. Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Sakamoto S; Morita K; Yukawa E; Kamimura H; Karube Y Scand J Infect Dis; 2012 Aug; 44(8):626-9. PubMed ID: 22263918 [TBL] [Abstract][Full Text] [Related]
8. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections. Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321 [TBL] [Abstract][Full Text] [Related]
9. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients. Plock N; Buerger C; Joukhadar C; Kljucar S; Kloft C Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029 [TBL] [Abstract][Full Text] [Related]
10. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. Dryden MS J Antimicrob Chemother; 2011 May; 66 Suppl 4():iv7-iv15. PubMed ID: 21521707 [TBL] [Abstract][Full Text] [Related]
11. Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics. Viaggi B; Paolo AD; Danesi R; Polillo M; Ciofi L; Del Tacca M; Malacarne P Scand J Infect Dis; 2011 Sep; 43(9):721-7. PubMed ID: 21585240 [TBL] [Abstract][Full Text] [Related]
12. Effect of severity of sepsis on tissue concentrations of linezolid. Thallinger C; Buerger C; Plock N; Kljucar S; Wuenscher S; Sauermann R; Kloft C; Joukhadar C J Antimicrob Chemother; 2008 Jan; 61(1):173-6. PubMed ID: 17999976 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of linezolid during extracorporeal membrane oxygenation. De Rosa FG; Corcione S; Baietto L; Ariaudo A; Di Perri G; Ranieri VM; D'Avolio A Int J Antimicrob Agents; 2013 Jun; 41(6):590-1. PubMed ID: 23453617 [No Abstract] [Full Text] [Related]
15. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration. George JM; Fiscella R; Blair M; Rodvold K; Ulanski L; Stokes J; Blair N; Pontiggia L J Ocul Pharmacol Ther; 2010 Dec; 26(6):579-86. PubMed ID: 20977368 [TBL] [Abstract][Full Text] [Related]
16. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections. Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547 [TBL] [Abstract][Full Text] [Related]
17. Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects? Hamilton R; Thai XC; Ameri D; Pai MP J Antimicrob Chemother; 2013 Mar; 68(3):666-73. PubMed ID: 23160755 [TBL] [Abstract][Full Text] [Related]
18. Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring. Tröger U; Drust A; Martens-Lobenhoffer J; Tanev I; Braun-Dullaeus RC; Bode-Böger SM Int J Antimicrob Agents; 2012 Oct; 40(4):370-2. PubMed ID: 22795654 [TBL] [Abstract][Full Text] [Related]
19. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients. Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880 [TBL] [Abstract][Full Text] [Related]
20. Single dose pharmacokinetics of linezolid in infants and children. Kearns GL; Abdel-Rahman SM; Blumer JL; Reed MD; James LP; Jacobs RF; Bradley JA; Welshman IR; Jungbluth GL; Stalker DJ; Pediatr Infect Dis J; 2000 Dec; 19(12):1178-84. PubMed ID: 11144380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]